A Trial to Assess the Effect of an Intervention Integrating Contingency Management (Financial Incentives) to Enhance Hepatitis C Treatment Uptake Following Dried Blood Spot Hepatitis C RNA Testing Among People With Recent Injecting Drug Use Attending Needle and Syringe Programs (AMPLIFY)

K

Kirby Institute

Status

Not yet enrolling

Conditions

Hepatitis C, Chronic

Treatments

Behavioral: Incentive payment

Study type

Interventional

Funder types

Other

Identifiers

NCT04428346
VHCRP2004

Details and patient eligibility

About

A pilot two-arm, individual-level, randomised controlled trial to assess the effect of an intervention integrating contingency management (financial incentives) to enhance hepatitis C treatment uptake following dried blood spot hepatitis C RNA testing among people with recent injecting drug use attending needle and syringe programs: the AMPLIFY study

Enrollment

400 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Participants have voluntarily signed the informed consent form
  • 18 years of age or older
  • Recent injecting drug use (previous six months)

Exclusion criteria

1) Inability or unwillingness to provide informed consent

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

400 participants in 2 patient groups

Contigency Management (Intervention)
Active Comparator group
Treatment:
Behavioral: Incentive payment
Standard of Care (Control)
No Intervention group

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems